Healthcare/Information Technology
Name:
Sector:
Chief Executive:
NGM
Healthcare/Life Sciences
David Goeddel
Summary:
NGM Biopharmaceuticals is an early stage company focused on the discovery and development of breakthrough therapeutics for metabolic diseases.
Stage of Initial
Investment:
Venture
Liquidity:
Private
Copyright ©2007 Rho Capital Partners, Inc.
